These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The treatment of erythema nodosum leprosum with B.663. A controlled study. Pettit JH Int J Lepr Other Mycobact Dis; 1967; 35(1):11-6. PubMed ID: 4290017 [No Abstract] [Full Text] [Related]
4. The effect of stopping dapsone treatment for two months and then restarting it in full dosage in patients with moderately severe erythema nodosum leprosum. Pearson JM; Helmy HS Lepr Rev; 1973 Jun; 44(2):75-82. PubMed ID: 4733886 [No Abstract] [Full Text] [Related]
5. Double-blind controlled clinical trial of clofazimine in reactive phases of lepromatous leprosy. Karat AB; Jeevaratnam A; Karat S; Rao PS Br Med J; 1970 Jan; 1(5690):198-200. PubMed ID: 4904935 [TBL] [Abstract][Full Text] [Related]
6. Forty-four months' experience in the treatment of leprosy with clofazimine (Lamprene (Geigy)). Schulz EJ Lepr Rev; 1971 Sep; 42(3):178-87. PubMed ID: 5151819 [No Abstract] [Full Text] [Related]
7. Efficacy of clofazimine in the prophylaxis and suppression of reactive phases of lepromatous leprosy. Karat AB; Jeevaratnam A; Karat S; Rao PS Int J Lepr Other Mycobact Dis; 1971; 39(4):838-41. PubMed ID: 5170472 [No Abstract] [Full Text] [Related]
9. Possible incompatibility of dapsone with clofazimine in the treatment of patients with erythema nodosum leprosum. Imkamp FM; Anderson R; Gatner EM Lepr Rev; 1982 Jun; 53(2):148-9. PubMed ID: 7098753 [No Abstract] [Full Text] [Related]
10. The relationship of dapsone (DDS) therapy to erythema nodosum leprosum. Is it direct or indirect? Waters MF; Helmy HS Lepr Rev; 1974 Dec; 45(4):299-307. PubMed ID: 4613978 [No Abstract] [Full Text] [Related]
12. Antibacterial effects of G 30'320 Geigy (B663) in lepromatous leprosy. Hastings RC; Trautman JR; Mansfield RE Dermatol Int; 1969; 8(1):21-7. PubMed ID: 5343403 [No Abstract] [Full Text] [Related]
13. Thalidomide in the treatment of erythema nodosum leprosum. With a note on selected laboratory abnormalities in erythema nodosum leprosum. Hastings RC; Trautman JR; Enna CD; Jacobson RR Clin Pharmacol Ther; 1970; 11(4):481-7. PubMed ID: 4913866 [No Abstract] [Full Text] [Related]
14. A Traditional NSAID Aspirin along with Clofazimine in Erythema Nodosum Leprosum Reaction: Study of Six Cases. Sharma PK; Singh DK Indian J Lepr; 2016 Sep; 87(4):249-253. PubMed ID: 29762954 [TBL] [Abstract][Full Text] [Related]
15. [Clofazimine. Current status of therapy with clofazimine (Lampren) for leprosy, erythema leprosum , and other dermatoses after donation of the medicine to the WHO by Novartis]. Sunderkötter CH; Lan Ma H Hautarzt; 2005 May; 56(5):478-9. PubMed ID: 15806433 [No Abstract] [Full Text] [Related]
16. Controlled long-term therapy of leprosy with B663 (lamprene, clofazimine) compared with DDS. Tolentino JG; Rodriquez JN; Abalos RM Int J Lepr Other Mycobact Dis; 1974; 42(4):416-418. PubMed ID: 4617720 [No Abstract] [Full Text] [Related]
17. Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy. Waters MF; Rees RJ; Sutherland I Int J Lepr Other Mycobact Dis; 1967; 35(3):311-35. PubMed ID: 4917107 [No Abstract] [Full Text] [Related]
18. A treatment of corticosteroid-dependent lepromatous patients in persistent erythema nodosum leprosum. A clinical evaluation of G.30320 (B663). Imkamp FM Lepr Rev; 1968 Jul; 39(3):119-25. PubMed ID: 4298736 [No Abstract] [Full Text] [Related]